Thema
COVID-19
Letter
SARS-CoV-2
366
Comment
359
Research Support, Non-U.S. Gov't
123
Coronavirus
114
Case Reports
101
Clinical Trial Protocol
82
coronavirus
78
Randomised controlled trial
72
Pandemic
63
protocol
63
Antiviral Agents
49
Hydroxychloroquine
42
pandemic
42
severe acute respiratory syndrome coronavirus 2
41
4QWG6N8QKH
39
RNA, Viral
37
EC 3.4.15.1
36
Peptidyl-Dipeptidase A
36
viruses
36
Angiotensin-Converting Enzyme 2
34
EC 3.4.17.23
34
Protocol
33
respiratory infections
33
zoonoses
33
Antibodies, Viral
31
Review
31
coronavirus disease
31
ACE2 protein, human
29
Biomarkers
29
Antibodies, Monoclonal, Humanized
28
Comparative Study
28
Anticoagulants
25
Aerosols
23
Multicenter Study
23
Randomized Controlled Trial
23
Research Support, N.I.H., Extramural
23
Mental health
22
Meta-Analysis
22
Pandemics
22
Public health
22
tracheal intubation
22
Cytokines
21
Infectious diseases
21
Mortality
21
airway management
21
2019 novel coronavirus disease
20
ACE2
20
ARDS
19
mehr ...